Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 166

The DOI matches its Crossref record.

Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC‐MS/MS

Heo, Sun‐Hee, Lee, Seung‐Jin, Ryoo, Hyun‐Mo, Park, Jae‐Yong, Cho, Je‐Yoel · 2007 · PROTEOMICS

Abstract

Glycoproteins in human serum play fundamental roles in many biological processes, and also have clinical value as biomarkers for disease progression and treatment. In this study, we isolated glycoproteins from the sera of three healthy individuals and three lung adenocarcinoma patients using multilectin affinity chromatography. The recovered glycoproteins were subjected to treatment with peptide‐N‐glycosidase F (PNGase F) and in‐gel digestion by trypsin. Tryptic peptides were analyzed by nano‐LC coupled to ESI‐MS/MS and the MS/MS spectra were processed by Bioworks 3.2 and an in‐house bioinformatics tool, ProtAn. Approximately 90% of the proteins identified contained more than one potential glycosylation site. Comparison of the serum glycoproteome of healthy and adenocarcinoma individuals revealed 38 cancer‐selective proteins. Among them, 60% have previously been reported as low abundance proteins in human sera. We identified several cancer‐selective proteins that have been previously characterized as potential indicators of lung cancer in serum or plasma, including haptoglobin (HP), inter‐α‐trypsin inhibitor heavy chain 4 (ITI‐H4), complement C3 precursor, and leucine‐rich α‐2‐glycoprotein. In addition, plasma kallikrein (KLKB1) and inter‐α‐trypsin inhibitor heavy chain 3 (ITI‐H3) were identified as being potentially elevated in the lung cancer group, and were validated by Western blot analysis. Furthermore, ∼18 kDa plasma kallirein protein fragment was detected at high levels in 25 out of 28 adenocarcinoma patients, while one of the eight normal individuals showed moderate positive. The results suggest that KLKB1 represents a potential candidate serum biomarker of lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pmic.200700433

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Heo, S., Lee, S., Ryoo, H., Park, J., & Cho, J.
Venue
PROTEOMICS
Publisher
Wiley
Published
2007-11-26
Volume
7
Issue
23
Pages
4292-4302
ISSN
  • 1615-9853 (ISSN-L)
  • 1615-9861
OpenAlex
W2086142657
Cited by
166
References
0
FWCI
5.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC‐MS/MS. https://app.cochat.ai/papers/10.1002/pmic.200700433
The paper
Heo, S., Lee, S., Ryoo, H., Park, J., & Cho, J. (2007). Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC‐MS/MS. PROTEOMICS. https://doi.org/10.1002/pmic.200700433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.